Company / Current Assets per Share
Jade Biosciences, Inc. Current Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.80
FY2024
5-year range
$2.80 / $19.30
FY2020-FY2024
Trend
-40.6%
vs FY2023
Sector context
#161 of 208
Health Care
What the data says
Jade Biosciences, Inc.'s current assets per share of $2.80 is lower than 77% of companies in the Health Care sector (FY2024). Current Assets per Share has declined for 4 consecutive years, from $19.30 in FY2020 to $2.80 in FY2024.
Based on SEC 10-K filings.
2.80 in FY2024 with a 3-year CAGR of -41.7%.
Declined from $5.37 to $2.80 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -41.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 208This company $2.80 Sector average $186.87
▼
-98.5% below sector average
Key checks
Key Insights
- Jade Biosciences, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2024, current assets per share decreased 40.6% year-over-year.
- Ranks #161 out of 208 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.80 | -40.6% |
| FY2023 | $4.72 | -12.2% |
| FY2022 | $5.37 | -62.1% |
| FY2021 | $14.18 | -26.5% |
| FY2020 | $19.30 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026